CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >

2020 , Vol. 38 >Issue 1: 53 - 57

DOI: https://doi.org/10.12140/j.issn.1000-7423.2020.01.021

SHORT COMMUNUCATIONS

Analysis of hospital expenses for patients with end-stage hepatic alveolar echinococcosis receiving ex vivo liver resection and autotransplantation

  • KASIMU Aihaiti ,
  • ABUDUSALAMU Aini ,
  • TUERGANAILI Aji ,
  • SHAO Ying-mei ,
  • ZHANG Rui-qing ,
  • TALAITI Tuergan ,
  • JIANG Tie-min ,
  • RAN Bo ,
  • ABUDUAINI Abulizi ,
  • MIERADILI Aierken ,
  • WEN Hao
Expand
  • 1 Department of Hepatobiliary and Hydatid Disease
    2 Xinjiang Uyghur Autonomous Region Clinical Research Center for Echinococcosis and Hepatobiliary Diseases
    3 Digestive and Vascular Surgery Center
    4 Emergency and Trauma Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
    5 State Key Laboratory of High Incidence Disease in Central Asia, Xinjiang Medical University, Urumqi 830011, China
*Corresponding author: E-mail: tuergan78@sina.com

Received date: 2019-08-22

  Online published: 2020-03-19

Supported by

Supported by Xinjiang Uyghur Autonomous Region Key Laboratory Open Research Program (No. 2017D04004)

Copyright

中华预防医学会和中国疾病预防控制中心寄生虫病预防控制所, 2020, 中华预防医学会和中国疾病预防控制中心寄生虫病预防控制所所有
Fold

Abstract

We retrospectively collected demographic information as well as relevant clinical data of patients with end-stage hepatic alveolar echinococcosis (AE) treated with ex vivo liver resection and autotransplantation (ELRA) in the First Affiliated Hospital of Xinjiang Medical University during 2010-2018. The patients were divided into six groups based on their medical history prior to ELRA: group A patients having no relevant disease history record; group B having anti-parasitic chemotherapy history; group C having the history of anti-parasitic chemotherapy plus hepatoprotective medication; group D having the record of alleviating jaundice by percutaneous or endoscopic approach plus hepatoprotective medication; group E experienced interventional treatment via liver blood vessel plus anti-parasitic chemotherapy; and group F experienced hepatectomy and anti-parasitic chemotherapy. The medical expenses of different groups were compared by the Mann-Whinty test. A total of 82 patients receiving ELRA were included in this study, with a male/female ratio of 39 : 43 and an average age of (36.12 ± 11.84) years. Most of them were of Zang, Kazakh and Han ethnity, and came from Xinjiang, Tibet and Sichuan. The medical expenses for the hepatic AE patients receiving ELRA treatment included the costs of western medicine, medical examinations, consumable material, ELRA surgery and special material. The average total expense of the 82 patients was (241 155.0 ± 119 746.5) yuan, of which the cost of western medicine accounting the highest proportion (41.1%), followed by the cost of medical examinations (15.7%), consumable material (13.4%), surgery (9.6%) and special material (7.5%). The groups C and D had significantly higher total expenses (P < 0.01) than the other 4 groups. When compared with itemized cost, the group C and D expensed significantly higher for western medicine, medical examinations, nursing, and treatment (P < 0.05), compared with other 4 groups. The group C and D also expensed significantly higher for special material, blood supply, emergency aid, and ward bed than those of group A (P < 0.05). The total and itemized expenses of the patients with no relevant disease history prior to surgery were lower than those with these history records. In addition, occurrence of jaundice or liver dysfunction may increase the total expense and the costs of most items.

Key words： Hepatic alveolar echinococcosis; Ex vivo liver resection and autotransplantation; Hospital cost

Cite this article

KASIMU Aihaiti , ABUDUSALAMU Aini , TUERGANAILI Aji , SHAO Ying-mei , ZHANG Rui-qing , TALAITI Tuergan , JIANG Tie-min , RAN Bo , ABUDUAINI Abulizi , MIERADILI Aierken , WEN Hao . Analysis of hospital expenses for patients with end-stage hepatic alveolar echinococcosis receiving ex vivo liver resection and autotransplantation[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2020 , 38(1) : 53 -57 . DOI: 10.12140/j.issn.1000-7423.2020.01.021

References

[1] Deplazes P, Rinaldi L, Alvarez Rojas CA, et al. Global distribution of alveolar and cystic echinococcosis[J]. Adv Parasitol, 2017, 95: 315-493.
[2] Wen H, Dong JH, Zhang JH, et al. Ex vivo liver resection followed by autotransplantation for end-stage hepatic alveolar echinococcosis[J]. Chin Med J, 2011, 124(18): 2813-2817.
[3] Aji T, Dong JH, Shao YM, et al. Ex vivo liver resection and auto transplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis[J]. J Hepatol, 2018, 69(5): 1037-1046.
[4] Wen H, Dong JH, Zhang JH, et al. Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: a case series[J]. Am J Transplant, 2016, 16(2): 615-624.
[5] Duan XY, Wei JJ, Wang L, et al. Direct economic burden of inpatients with echinococcosis in primary hospitals in Xinjiang[J]. Pract Prev Med, 2015, 22(10): 1164-1166. (in Chinese)
  (段新宇, 魏晶晶, 王乐, 等. 新疆基层医院包虫病住院患者直接经济负担分析[J]. 实用预防医学, 2015, 22(10): 1164-1166.)
[6] Chinese Doctor Association, Chinese College of Surgeons (CCS), Chinese Committee for Hadytidology (CCH). Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. (in Chinese)
  (中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721.)
[7] Abudusalamu A, Shao Y, Tuerganaili A, et al. Establishment and innovative practice of integrative system of prevention, diagnosis and management for echinococcosis in China[J]. Chin J Parasitol Parasit Dis, 2019, 37(4): 388-394. (in Chinese)
  (阿卜杜萨拉木·艾尼, 邵英梅, 吐尔干艾力·阿吉, 等. 中国棘球蚴病防诊治体系建设与创新实践[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(4): 388-394)
[8] Li J, Guo G, Zhang ZZ, et al. Physiological characteristics of Echinococcus and their association with interventions against echinococcosis[J]. Chin J Prev Med, 2018, 52(2): 210-214. (in Chinese)
  (李军, 郭刚, 张壮志, 等. 棘球绦虫的主要生理学特点与包虫病控制方法的确立[J]. 中华预防医学杂志, 2018, 52(2): 210-214.)
[9] Yang MY.Health Communication strategies for prevention and control on echinococcosis among agro-pastoralists of the Western China [D]. Nanning: Guangxi University, 2017. (in Chinese)
  (杨名宜. 西部五省区农牧民包虫病健康传播策略研究[D]. 南宁: 广西大学, 2017.)
[10] Duan XY.Study on the economic burden of the hydatid patients with surgical salvage project in Xinjiang [D]. Urumqi: Xinjiang medical university, 2014. (in Chinese)
  (段新宇. 新疆包虫病外科救助项目的疾病经济负担研究[D]. 乌鲁木齐: 新疆医科大学, 2014.)
[11] Pichlmayr R, Bretschneider HJ, Kirchner E, et al. Ex situ operation on the liver. A new possibility in liver surgery[J]. Langenbecks Arch Chir, 1988, 373(2): 122-126.
[12] Tuerganaili Aji, Shao YM, Zhao JM, et al. The clinical practice of improvement the “Volume and Quality” of functional liver in autologous liver transplantation for the patients with alveolar echinococcosis[J]. Natl Med J China, 2017, 97(4): 270-275. (in Chinese)
  (吐尔干艾力·阿吉, 邵英梅, 赵晋明, 等. 肝泡型包虫病自体肝移植中提升功能肝“量与质”的临床实践: 附12例临床病例分析[J]. 中华医学杂志, 2017, 97(4): 270-275.)
[13] Cosic L, Ma R, Churilov L, et al. The financial impact of postoperative complications following liver resection[J]. Medicine, 2019, 98(27): e16054.
[14] Martin AN, Narayanan S, Turrentine FE, et al. Clinical factors and postoperative impact of bile leak after liver resection[J]. J Gastrointest Surg, 2018, 22(4): 661-667.
[15] Xie EB, Xuan FH, Sun XD, et al. An analysis of risk factors for early complications after liver transplantation[J]. J Clin Hepatol, 2018, 34(6): 145-151. (in Chinese)
  (解恩博, 轩凤慧, 孙晓东, 等. 肝移植术后早期并发症的危险因素分析[J]. 临床肝胆病杂志, 2018, 34(6): 145-151.)
[16] Wang ZX, Qin LX.Prevention and treatment of complications after liver transplantation[J]. Chin J Bases Clin Gen Surg, 2018, 25(9): 7-12. (in Chinese)
  (王正昕, 钦伦秀. 肝移植术后并发症的防治现状及进展[J]. 中国普外基础与临床杂志, 2018, 25(9): 7-12.)
[17] Study Group of Surgical Operation, Chinese Society of Surgery, Chinese Medical Association; China International Exchange, and Promotive Association for Medical, and Health Care; Hepatic Surgery Group, Society of Enhanced Recovery After surgery. Chinese expert consensus on enhanced recovery after hepatectomy(2017)[J]. J Clin Hepatol, 2017, 6(4): 254-260. (in Chinese)
  (中华医学会外科学分会外科手术学学组, 中国医疗保健国际交流促进会加速康复外科学分会肝脏外科学组. 肝切除术后加速康复中国专家共识(2017版)[J]. 中华肝脏外科手术学电子杂志, 2017, 6(4): 254-260.)
Options
Outlines

/

〈 〉